Login

R1 RCM Inc. /DE 8-K SEC Filings

Filed On Filing
19 Nov 2024 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +8 more

Section 1. Registered Office. The registered office of R1 RCM Inc. (hereinafter, the “Corporation”) in the State of Delaware shall be located at Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware 19801, in the County of N...

14 Nov 2024 8-K: Submission of Matters to a Vote of Security Holders

As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Raven Acquisition Holdings, LLC, a Delaware limited liability comp...

05 Nov 2024 8-K: Results of Operations and Financial Condition

Murray, Utah - November 5, 2024 - R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announc...

22 Oct 2024 8-K: Results of Operations and Financial Condition

As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger with Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), and Proje...

04 Oct 2024 8-K: Regulation FD Disclosure

As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger with Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), and Proje...

16 Sep 2024 8-K: Other Events

As previously announced, on July 31, 2024, R1 RCM Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Raven Acquisition Holdings, LLC, a Delaware limited liability comp...

07 Aug 2024 8-K: Results of Operations and Financial Condition

Murray, Utah - August 7, 2024 - R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced...

01 Aug 2024 8-K: Entry into a Material Definitive Agreement; Other Events

THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 31, 2024, by and among Raven Acquisition Holdings, LLC, a Delaware limited liability company (“Parent”), Project Raven Merger Sub, Inc., a Delaware ...

22 May 2024 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders

This Fifth Amended and Restated 2010 Stock Incentive Plan (the “Plan”) of R1 RCM Inc., a Delaware corporation formerly known as Accretive Health, Inc. (the “Company”), is effective as of April 8, 2024 (the “Effective Date”), and amends a...

08 May 2024 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Murray, Utah - May 8, 2024 - R1 RCM Inc. (NASDAQ: RCM) (“R1” or the “Company”), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and physicia...

19 Mar 2024 8-K: Other Events

As previously disclosed on March 11, 2024, the Board of Directors of R1 RCM Inc. (the “Company”) formed a special committee comprised solely of independent directors (the “Special Committee”), to evaluate all strategic alternatives in re...

27 Feb 2024 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

Murray, Utah - February 27, 2024 - R1 RCM Inc. (NASDAQ: RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the financial performance and patient experience for health systems, hospitals, and ph...

15 Feb 2024 8-K: Departure/Election of Directors or Officers; Compensation

On February 15, 2024, the Board of Directors (the “Board”) of R1 RCM Inc. (the “Company”) appointed Pamela L. Spikner as principal accounting officer of the Company, effective immediately. Ms. Spikner’s appointment follows Mr. Evans’ not...

06 Feb 2024 8-K: Entry into a Material Definitive Agreement

This Amendment No. 1 to Investor Rights Agreement, dated as of February 5, 2024 (this "Amendment"), is entered into by and among R1 RCM Inc., a Delaware corporation (the "Company"), CoyCo 1, L.P., a Delaware limited partnership ("Coyco 1...

17 Jan 2024 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +4 more

This AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) dated as of January 17, 2024, to the Second Amended and Restated Credit Agreement, dated as of June 21, 2022 (as amended by that certain Amendment No...

08 Jan 2024 8-K: Results of Operations and Financial Condition

MURRAY, UT – January 8, 2024 – R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced preliminary fourt...

19 Dec 2023 8-K: Departure/Election of Directors or Officers; Compensation

On December 18, 2023, the Board of Directors (the “Board”) of R1 RCM Inc. (the “Company”) appointed Clay Ashdown as a director of the Company, effective as of December 18, 2023, to serve until the Company’s 2024 Annual Meeting of Stockho...

06 Dec 2023 8-K: Unregistered Sales of Equity Securities; Regulation FD Disclosure +1 more

R1 RCM to Acquire Acclara Acquisition of Providence’s Current Modular Services Business Accompanied by 10-Year Agreement to Provide Comprehensive Revenue Cycle Management Services

17 Nov 2023 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule; Regulation FD Disclosure

MURRAY, UT – November 17, 2023 -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced that, as anticipated,...

13 Nov 2023 8-K: Non-Reliance on Previously Issued Financial Statements; Regulation FD Disclosure

R1 RCM to Restate Certain Previously Issued Financial Statements Due to Errors in Accounting for Expenses Associated with Historical Acquisitions

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support